Related Experiment Video
Updated: Jun 27, 2026
11:58
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
Prospects for immunotoxin therapy in cancer
Annual Review of Medicine
|January 1, 1986
Summary
Immunotoxins, which link antibodies to toxic proteins, target cancer cells by inactivating protein synthesis. This chapter explores their potential clinical applications in cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Immunotoxins are hybrid molecules combining antibody specificity with cytotoxic polypeptide activity.
- Antibodies direct immunotoxins to target cells, such as tumor cells.
- The cytotoxic moiety enters the target cell and inhibits protein synthesis, leading to cell death.
Purpose of the Study:
- To examine a stepwise approach for identifying potential clinical uses of immunotoxins.
- To explore the therapeutic potential of immunotoxins in cancer treatment.
Main Methods:
- The chapter reviews the mechanism of action of immunotoxins.
- It discusses the principles guiding the development and application of immunotoxins in a clinical setting.
Main Results:
- Immunotoxins offer a targeted approach to cancer therapy by selectively delivering cytotoxic payloads to tumor cells.
- The antibody component ensures specific binding to cancer cells, minimizing off-target effects.
Conclusions:
- Immunotoxins represent a promising strategy for cancer treatment due to their targeted mechanism.
- Further research and a systematic approach are necessary to fully realize their clinical potential in oncology.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...